{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:40:06Z","timestamp":1787647206330,"version":"build-2736575974"},"reference-count":43,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,3,1]]},"DOI":"10.1210\/jc.2002-020667","type":"journal-article","created":{"date-parts":[[2003,3,10]],"date-time":"2003-03-10T21:02:44Z","timestamp":1047330164000},"page":"1174-1178","source":"Crossref","is-referenced-by-count":145,"title":["Raloxifene Lowers Serum Calcium and Markers of Bone Turnover in Postmenopausal Women with Primary Hyperparathyroidism"],"prefix":"10.1210","volume":"88","author":[{"given":"Mishaela R.","family":"Rubin","sequence":"first","affiliation":[{"name":"Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen H.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"McMahon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shonni J.","family":"Silverberg","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041117530430600_R1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0889-8529(05)70145-6","article-title":"Natural history of primary hyperparathyroidism.","volume":"29","author":"Silverberg","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041117530430600_R2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2362.1988.tb01163.x","article-title":"Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values.","volume":"18","author":"Palmer","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"2019041117530430600_R3","volume-title":"The parathyroid glands and metabolic bone disease","author":"Albright","year":"1948"},{"key":"2019041117530430600_R4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(72)90173-0","article-title":"Treatment with with oestrogens of primary hyperparathyroidism in post-menopausal women.","volume":"1","author":"Gallagher","year":"1972","journal-title":"Lancet"},{"key":"2019041117530430600_R5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/jcem-72-2-401","article-title":"Evidence for a renal calcium leak in postmenopausal women.","volume":"72","author":"Nordin","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117530430600_R6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-100-5-633","article-title":"Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism.","volume":"100","author":"Marcus","year":"1984","journal-title":"Ann Intern Med"},{"key":"2019041117530430600_R7","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJM198606053142304","article-title":"Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women.","volume":"314","author":"Selby","year":"1986","journal-title":"N Engl J Med"},{"key":"2019041117530430600_R8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.","volume":"125","author":"Grey","year":"1996","journal-title":"Ann Intern Med"},{"key":"2019041117530430600_R9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jbmr.5650110615","article-title":"A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women.","volume":"11","author":"Draper","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2019041117530430600_R10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-114-7-593","article-title":"NIH conference: diagnosis and management of asymptomatic primary hyperparathyroidism\u2014consensus development conference statement.","volume":"114","year":"1991","journal-title":"Ann Intern Med"},{"key":"2019041117530430600_R11","first-page":"14","article-title":"The design and analysis of clinical experiments","author":"Fleiss","year":"1986","journal-title":"New York: Wiley & Sons;"},{"key":"2019041117530430600_R12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"2019041117530430600_R13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism.","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2019041117530430600_R14","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/clinchem\/31.10.1720","article-title":"Determination of osteocalcin in human serum: results with two kits compared with those by a well-characterized assay.","volume":"31","author":"Gundberg","year":"1985","journal-title":"Clin Chem"},{"key":"2019041117530430600_R15","first-page":"3537","article-title":"Early changes in serum Ntelopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women.","volume":"85","author":"Greenspan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117530430600_R16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1359\/jbmr.2000.15.3.594","article-title":"Biological variability of serum and urinary N-telopeptides of type I collagen in postmenopausal women.","volume":"15","author":"Eastell","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2019041117530430600_R17","first-page":"2036","article-title":"Evaluation and management of primary hyperparathyroidism.","volume":"81","author":"Silverberg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117530430600_R18","first-page":"481","article-title":"Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism.","volume":"74","author":"Seibel","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117530430600_R19","first-page":"S121","article-title":"Characterization and evaluation of asymptomatic primary hyperparathyroidism","author":"Bilezikian","year":"1991","journal-title":"J Bone Miner Res 6(Suppl 2):S85\u2013S89;"},{"key":"2019041117530430600_R20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure.","volume":"70","author":"Parisien","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117530430600_R21","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","article-title":"Primary hyperparathyroidism and the risk of fracture: a population-based study.","volume":"14","author":"Khosla","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2019041117530430600_R22","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1001\/archinte.1987.00370110079012","article-title":"What is the clinical significance of bone loss in primary hyperparathyroidism?","volume":"147","author":"Kochersberger","year":"1987","journal-title":"Arch Intern Med"},{"key":"2019041117530430600_R23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2796.1993.tb01017.x","article-title":"The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years.","volume":"234","author":"Larsson","year":"1993","journal-title":"J Intern Med"},{"key":"2019041117530430600_R24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.7326\/0003-4819-109-12-959","article-title":"Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures.","volume":"109","author":"Wilson","year":"1988","journal-title":"Ann Intern Med"},{"key":"2019041117530430600_R25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0039-6060(05)80017-0","article-title":"Fracture incidence in postmenopausal women with primary hyperparathyroidism.","volume":"118","author":"Kenny","year":"1995","journal-title":"Surgery"},{"key":"2019041117530430600_R26","first-page":"S151","article-title":"Diagnosis and management of asymptomatic hyperparathyroidism: safety, efficacy, and deficiencies in our knowledge","author":"Clark","year":"1991","journal-title":"J Bone Miner Res 6(Suppl 2):S135\u2013S142;"},{"key":"2019041117530430600_R27","first-page":"727","article-title":"Medical management of primary hyperparathyroidism.","volume":"2","year":"1984","journal-title":"Lancet"},{"key":"2019041117530430600_R28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jcem-56-5-953","article-title":"A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyroidism.","volume":"56","author":"Broadus","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117530430600_R29","first-page":"941","article-title":"Lethal hyperparathyroid crisis: hazards of phosphate administration.","volume":"102","author":"Vernava III","year":"1987","journal-title":"Surgery"},{"key":"2019041117530430600_R30","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199711203372104","article-title":"Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism.","volume":"337","author":"Silverberg","year":"1997","journal-title":"N Engl J Med"},{"key":"2019041117530430600_R31"},{"key":"2019041117530430600_R32"},{"key":"2019041117530430600_R33"},{"key":"2019041117530430600_R34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.","volume":"16","author":"Rossini","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2019041117530430600_R35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-118-5-199303010-00003","article-title":"Estrogen protection against bone resorbing effects of parathyroid hormone infusion. Assessment by use of biochemical markers.","volume":"118","author":"Cosman","year":"1993","journal-title":"Ann Intern Med"},{"key":"2019041117530430600_R36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01623394","article-title":"Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report.","volume":"6","author":"Diamond","year":"1996","journal-title":"Osteop Int"},{"key":"2019041117530430600_R37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jbmr.5650090410","article-title":"Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy.","volume":"9","author":"McDermott","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2019041117530430600_R38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"2019041117530430600_R39","first-page":"3425","article-title":"Raloxifene and estrogen: comparative bone-remodeling kinetics.","volume":"82","author":"Heaney","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117530430600_R40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1359\/jbmr.2001.16.1.189","article-title":"Raloxifene reverses bone loss in postmenopausal women with mild asymptomatic primary hyperparathyroidism.","volume":"16","author":"Zanchetta","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2019041117530430600_R41","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1210\/endo.139.10.6216","article-title":"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor \u03b2.","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"key":"2019041117530430600_R42","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.277.5331.1508","article-title":"Differential ligand activation of estrogen receptors ER\u03b1 and ER\u03b2 at AP1 sites.","volume":"277","author":"Paech","year":"1997","journal-title":"Science"},{"key":"2019041117530430600_R43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJM199507273330407","article-title":"Calcium-ion-sensing cell-surface receptors.","volume":"333","author":"Brown","year":"1995","journal-title":"N Engl J Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/88\/3\/1174\/9149502\/jcem1174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T16:31:21Z","timestamp":1584462681000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/88\/3\/1174\/2845282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2002-020667","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,1]]}}}